v3.26.1
Segment and Geographic Information - Schedule of Segment Information - Summary of Financial Information (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Segment Reporting [Line Items]        
Total revenue $ 161,178 $ 143,855 $ 454,615 $ 434,629
Segment adjusted operating income (loss) 4,596 6,779 (1,742) 6,517
Amortization expense 5,700 6,200 16,800 18,400
Transformation costs 272 1,542 1,913 9,771
Restructuring charges 513 754 3,078 4,765
Impairment of goodwill and intangible assets 0 0 149,083 0
Merger and acquisition costs 2,248 58 4,436 2,316
Purchase accounting and other adjustments 43 84 206 35
Operating loss (4,178) (1,850) (177,205) (28,745)
Interest income, net 3,825 4,973 13,310 13,760
Other income (expenses), net 1,199 (820) 5,337 1,542
Income (loss) from continuing operations before income taxes 846 2,303 (158,558) (13,443)
Completed technology        
Segment Reporting [Line Items]        
Amortization expense 2,082 2,068 6,017 5,876
Other intangible assets        
Segment Reporting [Line Items]        
Amortization expense 3,616 4,123 10,730 12,499
Sample Management Solutions        
Segment Reporting [Line Items]        
Total revenue 88,289 77,620 250,804 238,575
Segment adjusted operating income (loss) 4,944 10,737 13,035 18,318
Restructuring charges 200 300 1,500 1,900
Operating loss 4,944 10,737 13,035 18,318
Multiomics        
Segment Reporting [Line Items]        
Total revenue 72,889 66,235 203,811 196,054
Segment adjusted operating income (loss) (348) (3,958) (14,777) (11,801)
Restructuring charges 100 400 1,400 2,100
Operating loss $ (348) $ (3,958) $ (14,777) $ (11,801)